Enveric Biosciences shareholders elect all six director nominees and approve say-on-pay at 2024 annual meeting

Enveric Biosciences, Inc.

All six director nominees elected; Michael D. Webb received 767,013 for, 107,751 withheld.
Say-on-pay proposal approved (711,513 for, 116,232 against); advisory frequency set to one year (774,619 votes).
Ratification of Marcum LLP as auditor for FY2024 approved (2,485,258 for, 170,212 against).
Approx. 2.8M shares (38.75% of outstanding) represented, establishing quorum at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.